— Know what they know.
Not Investment Advice
Also trades as: RMD.AX (ASX) · $vol 28M · 0KW4.L (LSE) · $vol 1M · RSMDF (OTC) · $vol 0M

RMD NYSE

ResMed Inc.
1W: +3.2% 1M: -5.9% 3M: -19.3% YTD: -14.4% 1Y: -15.4% 3Y: -6.4% 5Y: +11.2%
$208.05
-0.93 (-0.45%)
 
Weekly Expected Move ±3.9%
$186 $194 $202 $210 $218
NYSE · Healthcare · Medical - Devices · Alpha Radar Neutral · Power 51 · $30.2B mcap · 144M float · 0.799% daily turnover · Short 70% of daily vol

Cash Flow Trends

Operating Cash Flow
$1.8B +25.0% ▲
5Y CAGR: +16.9%
Capital Expenditures
$90M +21.8% ▲
5Y CAGR: -3.2%
Free Cash Flow
$1.7B +29.2% ▲
5Y CAGR: +19.0%
Dividends Paid
$311M -10.1% ▼
Buybacks
$300M -100.0% ▼
Net Change in Cash
$971M +9175.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$475M$779M$898M$1.0B$1.4B
Depreciation & Amort.$192M$194M$198M$216M$236M
Stock-Based Comp.$64M$65M$71M$80M$92M
Change in Working Capital$1M-$708M-$462M$45M$17M
Other Non-Cash Items$9M$21M-$11M$39M$7M
Operating Cash Flow$737M$351M$693M$1.4B$1.8B
— Investing Activities —
Capital Expenditures-$117M-$156M-$134M-$99M-$90M
Acquisitions (Net)-$39M-$43M-$1.0B-$133M-$139M
Investment Purchases-$22M-$21M-$32M-$22M-$6M
Investment Sales$0$7M$4M$1M$0
Other Investing$19M-$17M$15M-$15M$35M
Investing Cash Flow-$158M-$230M-$1.2B-$270M-$200M
— Financing Activities —
Net Debt Issuance-$522M$122M$665M-$730M-$40M
Stock Repurchased$0$0$0-$150M-$300M
Dividends Paid-$227M-$245M-$258M-$282M-$311M
Other Financing-$54M-$52M-$33M-$10M-$30M
Financing Cash Flow-$765M-$128M$423M-$1.1B-$606M
Net Change in Cash-$168M-$22M-$46M$10M$971M
Cash End of Period$295M$274M$228M$238M$1.2B
Free Cash Flow$620M$195M$559M$1.3B$1.7B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms